Daniel R Knight

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Topics

Antimicrobial Resistance

Irritable Bowel Syndrome

Top Venues

Microbiology resource announcements

Scientific reports

Journal of clinical microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel R Knight, Korakrit Imwattana, Deirdre A Collins, Su-Chen Lim, Stacey Hong, Papanin Putsathit, Thomas V Riley
Genomic epidemiology and transmission dynamics of recurrent Clostridioides difficile infection in Western Australia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements 12 (5) (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements 12 (5) (2023)
Korakrit Imwattana, Niraj Shivaperumal, Teera Leepattarakit, Pattarachai Kiratisin, Daniel R Knight, Thomas V Riley
The Brief Case: a White-Colony-Producing Clostridioides difficile Ribotype 020 Strain. Journal of clinical microbiology 61 (6) (2023)
Karla Cautivo-Reyes, Daniel R Knight, Deborah Bowie, Benjamin Moreira-Grez, Andrew S Whiteley, Thomas V Riley
Biogeographic distribution and molecular epidemiology of Clostridioides ( Clostridium ) difficile in Western Australian soils. Applied and environmental microbiology (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements 12 (5) (2023)
Nirajmohan Shivaperumal, Natasza M R Hain-Saunders, Barbara J Chang, Thomas V Riley, Daniel R Knight
Complete Genome Sequences of Evolutionary Clade C-III Strains of Clostridioides ( Clostridium ) difficile Isolated from the Environment in Western Australia. Microbiology resource announcements (2023)
Korakrit Imwattana, Daniel R Knight, Thomas V Riley
Can sequencing improve the diagnosis and management of Clostridioides difficile infection? Expert review of molecular diagnostics 21 (5) (2021)
Papanin Putsathit, Stacey Hong, Narelle George, Christine Hemphill, Peter G Huntington, Tony M Korman, Despina Kotsanas, Monica Lahra, Rodney McDougall, Andrew McGlinchey, Casey V Moore, Graeme R Nimmo, Louise Prendergast, Jennifer Robson, Lynette Waring, Michael C Wehrhahn, Gerhard F Weldhagen, Richard M Wilson, Thomas V Riley, Daniel R Knight
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18. The Journal of antimicrobial chemotherapy 76 (7) (2021)
Daniel R Knight, Korakrit Imwattana, Brian R Kullin, Enzo Guerrero-Araya, Daniel Paredes-Sabja, Xavier Didelot, Kate E Dingle, David W Eyre, César Rodríguez, Thomas V Riley
Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy. eLife 10 (2021)
Stacey Hong, Papanin Putsathit, Narelle George, Christine Hemphill, Peter G Huntington, Tony M Korman, Despina Kotsanas, Monica Lahra, Rodney McDougall, Casey V Moore, Graeme R Nimmo, Louise Prendergast, Jennifer Robson, Lynette Waring, Michael C Wehrhahn, Gerhard F Weldhagen, Richard M Wilson, Thomas V Riley, Daniel R Knight
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018. Journal of clinical microbiology 58 (11) (2020)
Su Chen Lim, Daniel R Knight, Peter Moono, Niki F Foster, Thomas V Riley
Clostridium difficile in soil conditioners, mulches and garden mixes with evidence of a clonal relationship with historical food and clinical isolates. Environmental microbiology reports 12 (6) (2020)
Korakrit Imwattana, Daniel R Knight, Brian Kullin, Deirdre A Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas V Riley
Clostridium difficile ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia. Emerging microbes & infections 8 (1) (2019)
Korakrit Imwattana, Daniel R Knight, Brian Kullin, Deirdre A Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas V Riley
Antimicrobial resistance in Clostridium difficile ribotype 017. Expert review of anti-infective therapy 18 (1) (2019)
Daniel R Knight, Brian Kullin, Grace O Androga, Frederic Barbut, Catherine Eckert, Stuart Johnson, Patrizia Spigaglia, Kazuhiro Tateda, Pei-Jane Tsai, Thomas V Riley
Evolutionary and Genomic Insights into Clostridioides difficile Sequence Type 11: a Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance. mBio 10 (2) (2019)
Masoumeh Azimirad, Fatemeh Gholami, Abbas Yadegar, Daniel R Knight, Sharareh Shamloei, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali
Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran. Scientific reports 9 (1) (2019)
Niloufar Roshan, Thomas V Riley, Daniel R Knight, Katherine A Hammer
Effect of natural products on the production and activity of Clostridium difficile toxins in vitro. Scientific reports 8 (1) (2018)
Nikki Y T Man, Daniel R Knight, Scott G Stewart, Allan J McKinley, Thomas V Riley, Katherine A Hammer
Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound. Scientific reports 8 (1) (2018)